MED - Medifast, Inc. (NYSE:MED)

[Grecale]

Fondamentali buoni, crescita in costante e corposo incremento, pochi debiti e buona cassa, p/e un pò altino ma con un forecast ragionevole.
Graficamente mi piace e molto.

Market Cap (intraday): 97.79M
Enterprise Value (27-Feb-04)³: 86.20M
Trailing P/E (ttm, intraday): 54.94
Forward P/E (fye 31-Dec-04)¹: 28.76
PEG Ratio (5 yr expected)¹: N/A
Price/Sales (ttm): 3.95
Price/Book (mrq): 6.61
Enterprise Value/Revenue (ttm)³: 3.59
Enterprise Value/EBITDA (ttm)³: 23.75


FINANCIAL HIGHLIGHTS

Fiscal Year
Fiscal Year Ends: 31-Dec
Most Recent Quarter (mrq): 30-Sep-03


Profitability
Profit Margin (ttm): 8.82%
Operating Margin (ttm): 12.96%


Management Effectiveness
Return on Assets (ttm): 15.90%
Return on Equity (ttm): 27.47%


Income Statement
Revenue (ttm): 24.03M
Revenue Per Share (ttm): 2.406
Revenue Growth (lfy)³: 145.80%
Gross Profit (ttm)²: 8.66M
EBITDA (ttm): 3.63M
Net Income Avl to Common (ttm): 1.93M
Diluted EPS (ttm): 0.178
Earnings Growth (lfy)³: 346.10%


Balance Sheet
Total Cash (mrq): 8.39M
Total Cash Per Share (mrq): 0.84
Total Debt (mrq)²: 4.93M
Total Debt/Equity (mrq): 0.326
Current Ratio (mrq): 4.017
Book Value Per Share (mrq): 1.434


Cash Flow Statement
From Operations (ttm)³: 1.71M
Free Cashflow (ttm)³: -1.25M

 

[Grecale]

http://biz.yahoo.com/prnews/040224/phtu012_1.html

http://biz.yahoo.com/prnews/031212/phf003_1.html

 

[Grecale]

Il suo business mi sembra ottimo e risponde ad un grande problema americano
http://www.medifastdiet.com/investorinfo/press_releases/2-4-04.htm

Ragà ditemi come vi sembra

 

[altolivello]

ciao grec,,,,,

io personalmento la vedo ottima sui 5,80 -6 dollari,,,

credo che la candela bianca sia un falso segnale,,

la mia immaginazione la vede proiettata sui 6 dollari,,,,

ripeto e' un punto di vista che sara' sicuramente smentito,,,,

io entrerei solo a quel livello,,,

credo sia cara,,,basta guardare gli insider che le hanno caricate a 60 cent, nel 2001 e sfruttano ogni momento di rialzo per uscire,,,,

ti credo,,,,,60 cent,,a 11 dollari,,,capzo in 2 anni sono una gran bella cifra,,,,,

credo che scaricheranno ancora fino a 6 dollari,,

ho detto la mia my friend,,,,,

se le hai ti auguro una grande performance ma se non le hai pensaci bene,,,

 

[Grecale]

Ciao Rino, heheheheh tutto può essere in borsa, ed io come sai sono spudorato quanto prudente.
Ma Med graficamente non mi sembra abbia intenzione di scendere ancora, anzi io vedo un elastico a fionda..............
Cmq. non sono dentro e la seguirò ...vedremo
Certo se dovesse beccare un downgrade quello da te indicato sarebbe il suo obiettivo naturale, ma i risultati 2003 cosi come il primo quarter vanno nella direzione opposta.
Per altro Med incomincia da poco a fare uso di strumenti mediatici, fondamentale per lo sviluppo del suo business.
Io sono ottimista seguirò gli oscillatori che sono un pò in conflitto vediamo cosa mi suggeriranno nei prox gg

 

[Grecale]

parte al rialzo +9%

 

[Grecale]

perfetta và su a forza di gap
chiude sui max 10,80

 

[Grecale]

Sono solo su Med, cosi tanto per sapere, cosi non posto +

 

[stefano6661]

Molto interessante devo dire.

Earning suprise del 50% con aumento di fatturato e discreto book value.



Medifast Announces Second Quarter Results; 19th Consecutive Quarter of Profitability
Monday August 16, 4:00 pm ET
Revenues Increase 16% while Domestic Sales Grow 24%; Company Affirms Full-year Forecast as Domestic Sales Remain Strong


OWINGS MILLS, Md., Aug. 16 /PRNewswire-FirstCall/ -- Medifast, Inc. (Amex: MED - News) announced today second quarter financial results for the period ended June 30, 2004. The company reported revenue of $7.4 million, a 16% increase versus $6.4 million in the year-earlier period and $200,000 above its previously announced estimate on July 2, 2004. Domestic sales increased 24% to $7.4 million. Income from Operations was $982,000, a 1.1% increase compared to $971,000 in the same period in 2003. The company reported pre-tax income of $925,000 compared to $959,000 in the second quarter of 2003. The company reported net income of $674,000, or $0.06 per basic share ($0.06 per diluted share), versus $591,000, or $0.06 per basic share ($0.05 per diluted share) in the 2003 second quarter. Net income was impacted by a higher share count as a result of the conversion of preferred stock into common stock. The Company did not owe Federal income taxes during the period.
ADVERTISEMENT


For the six months ended June 30, 2004, Medifast had revenue of $14.2 million, representing an 11% increase compared to $12.8 million reported for the six-month period ending June 30, 2003. Domestic sales increased 26% to $14.2 million. Income from Operations was $1,901,000 a decrease of 21% compared to $2,415,000 for the 2003 six-month period, due to increased sales costs and declines in international revenue. The company reported net income of $1,321,000, or $0.12 per basic share ($0.11 per diluted share), versus $1,455,000, or $0.17 per basic share ($0.14 per diluted share). Net income was impacted by a higher share count as a result of the conversion of preferred stock into common stock, as well as the sale of common stock in the capital raising completed in July of 2003. The Company did not owe Federal income taxes during the period.

Medifast ended the second quarter with $3.8 million in cash and cash equivalents. The Company had stockholders' equity of $18.4 million and working capital of $10.5 million on June 30, 2004, compared with $8.2 million and $3.0 million at June 30, 2003, respectively. During the second quarter, the Company purchased 1,500 shares of its common stock in the open market, per its Board of Directors authorization. The second quarter marked the Company's 19th consecutive quarter of profitability.

"We continue to see strong growth in our domestic business," said Brad MacDonald, Medifast's Chairman and Chief Executive Officer. "Our Take Shape for Life Network demonstrated another quarter of solid increases in the number of Health Advisors and sales. Our `Tasting Party Plans' have generated a great deal of enthusiasm from both our Health Advisors and new customers. Our Hi- Energy Clinics once again contributed significantly to our results, as we have now increased our licensed clinics to over 100 nationally. We continue to refine our advertising programs, as we seek to optimize the mix of national television advertising with direct mail and marketing programs. Despite the strong growth we have experienced in the U.S., our international sales have been disappointing. The conflict in Iraq has delayed key product launches in the Middle East and Far East, resulting in a decline of nearly $1.5 million in revenue during the first six months of the year from international sales."

"During the second quarter we invested aggressively in developing the infrastructure necessary to support a much larger business," continued MacDonald. "As a result, we now have the capacity to produce $200 million of product at our plants, which will support growth in our Take Shape for Life division as well as continued expansion of our Hi-Energy Clinics. We recently opened four corporate clinics in the Orlando market, and are excited about the licensee potential we believe these corporately run clinics will attract. Many of the new products that were delayed in the first half of the year have now been launched. The initial response to our new Maintain by Medifast(TM) product line was so strong on a national television retailer that we will appear again in October. As we further expand distribution over the coming quarters we expect the national television retailer relationship will be an important contributor to revenue. The combination of a strong balance sheet, significant infrastructure improvements which continue to reduce costs, promising new product launches and a rapidly growing clinic business should ensure that the future is bright for Medifast."

Some of the highlights of the second quarter include:

-- Johns Hopkins Study. The Company initiated a clinical study with
Johns Hopkins Bloomberg School of Public Health to test the efficacy
of Medifast meal replacements versus a standard reference diet. The
18-month study will consist of 80 overweight or obese boys and girls
between the ages of 8 and 15 along with 40 of their parents. The
clinical study will examine whether a joint parent-child approach
using Medifast's engineered foods will result in greater weight loss
than children dieting alone.

-- Key patent awarded. The Company was granted an official patent
(patent number 6,706,697) from the United States Patent and Trademark
Office for its Medifast Plus for Diabetics Shakes.

-- Launch of Take Shape for Life Business Opportunity video. Medifast
launched a new video designed to attract new Health Advisors and
customers to the company's innovative weight loss products. The
video will emphasize the lucrative business opportunity available to
potential Health Advisors. This recruitment tool will help stimulate
the growth of the Take Shape for Life network.


Subsequent to the end of the second quarter, the Company launched Maintain by Medifast(TM), a line of low-calorie, low-carbohydrate, diabetic friendly products. The line of low-glycemic shakes, bars and soups is backed by an ongoing clinical study in which participants achieved a weight loss of up to 2 pounds per week by incorporating the products into a 1,200 to 1,500 calorie per day meal plan. The Company will continue to rollout and expand the sale of Maintain by Medifast(TM) throughout the balance of the year.

 

[ffaiper]

Scritto da stefano6661
Molto interessante devo dire.

Earning suprise del 50% con aumento di fatturato e discreto book value.



che dici si entra????

preparo grafico,,ieri ha fatto harami bullish,oggi deve confermarlo

okkio a asia,,,,,,,,,,

 

[stefano6661]

Scritto da ffaiper

Scritto da stefano6661
Molto interessante devo dire.

Earning suprise del 50% con aumento di fatturato e discreto book value.



che dici si entra????

preparo grafico,,ieri ha fatto harami bullish,oggi deve confermarlo

okkio a asia,,,,,,,,,,

facile che apri in gap,anzi quasi sicuro,la trimestrale e' uscita ieri a mercati appena chiusi

 

[ffaiper]

Scritto da stefano6661
facile che apri in gap,anzi quasi sicuro,la trimestrale e' uscita ieri a mercati appena chiusi

non credo,,,essendo la conformazione di un harami bullish,,deve toccare almeno,il massimo della candela precedente,,,

io dico cosi,,,,comunque la seguiro dal premarket

 

[ffaiper]

weekly,,,il macd è alla fine del rosso,,,azzz,,,rimbalzino kiama

 

[stefano6661]

e' buona a questi prezzi se il mercato va su,ma non particolarmente eccezionale se il mercato dovesse scendere.

Insomma buona si ma fino ad un certo punto.Per il rimbalzo va bene,anche per un long se il nasdaq inverte.

 

[ffaiper]

Scritto da stefano6661
e' buona a questi prezzi se il mercato va su,ma non particolarmente eccezionale se il mercato dovesse scendere.

Insomma buona si ma fino ad un certo punto.Per il rimbalzo va bene,anche per un long se il nasdaq inverte.

per un rimbalzo,,ok,,,,,,tanto il nasqad inverte,,

 

[stefano6661]

Scritto da ffaiper
per un rimbalzo,,ok,,,,,,tanto il nasqad inverte,,

inverte?Quindi si tornera a fare nuovi massimi secono te'?

 

[Zantrax]

MA

POSSO SAPERE PERKE' SI PARLA DI EARNING SURPRISE DEL 50%??

DALLE STIME DI YAHOO VEDO 0,05
E INVECE LA SOCIETA' HA DATO 0,06

 

[Zantrax]

The Company did not owe Federal income taxes during the period.

SI TRATTA DI MED


DI CHE SI TRATTA?
SI RIFERISCE A QUESTO QUARTO O AL PROSSIMO?

 

[stefano6661]

Re: MA

Scritto da Zantrax
POSSO SAPERE PERKE' SI PARLA DI EARNING SURPRISE DEL 50%??

DALLE STIME DI YAHOO VEDO 0,05
E INVECE LA SOCIETA' HA DATO 0,06

Io ho visto qui.

 

[ffaiper]

Scritto da stefano6661
inverte?Quindi si tornera a fare nuovi massimi secono te'?

volevi dire nuovi minimi,,,,,,

per me il nasqad arriva al massimo a kiusura gap,,forse qualke punto piu sopra,,,dato ke la sma 7 sta incrociando la sma 200 in weekly,,,quindi rikiama un pull back,,come la sma 14 in daily a 1825,,stesso punteggio del gap aperto,,,,piu sopra non ce lo vedo,,se non parte un movimento rialzista da piu 2 al giorno,,,li potrei cambiare opinione